China NMPA Inspection - Zhejiang Taiste Biotechnology Co., Ltd. - January 08, 2020
China NMPA unannounced inspection for Zhejiang Taiste Biotechnology Co., Ltd. published January 08, 2020. The National Medical Products Administration (NMPA) announced on January 8, 2020, the suspension of production for Zhejiang Taiste Biotechnology Co.,
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA unannounced inspection for Zhejiang Taiste Biotechnology Co., Ltd. published January 08, 2020. The National Medical Products Administration (NMPA) announced on January 8, 2020, the suspension of production for Zhejiang Taiste Biotechnology Co.,
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
Unknown Date
Product Type
devices
ID: d0f87b3f-37af-4545-8685-22b69f1bcfce
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox